Medico Remedies

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE630Y01024
  • NSEID: MEDICO
  • BSEID: 540937
INR
47.18
-0.54 (-1.13%)
BSENSE

Jan 19

BSE+NSE Vol: 45.23 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Medico Remedies
Trident Lifeline
Haleos Labs Limi
Amanta Healthcar
Valiant Laborato
Zim Laboratories
Albert David
Nectar Lifesci.
Kerala Ayurveda
Solara Active PP
Influx Health.

Why is Medico Remedies Ltd ?

1
High Management Efficiency with a high ROCE of 15.04%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.89 times
3
The company has declared Positive results for the last 3 consecutive quarters
  • ROCE(HY) Highest at 20.65%
  • PAT(Q) At Rs 2.57 cr has Grown at 65.8%
  • DEBTORS TURNOVER RATIO(HY) Highest at 2.99 times
4
With ROCE of 15.8, it has a Fair valuation with a 5.2 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -28.74%, its profits have risen by 47.8% ; the PEG ratio of the company is 0.7
5
Reducing Promoter Confidence
  • Promoters have decreased their stake in the company by -1.21% over the previous quarter and currently hold 61.38% of the company
  • Promoters decreasing their stake may signify reduced confidence in the future of the business
6
Below par performance in long term as well as near term
  • Along with generating -28.74% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Medico Remedies should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Medico Remedies for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Medico Remedies
-28.74%
-0.48
59.54%
Sensex
8.65%
0.76
11.31%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
8.07%
EBIT Growth (5y)
35.36%
EBIT to Interest (avg)
8.34
Debt to EBITDA (avg)
1.08
Net Debt to Equity (avg)
0.16
Sales to Capital Employed (avg)
2.30
Tax Ratio
24.97%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.31%
ROCE (avg)
15.69%
ROE (avg)
17.20%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
34
Industry P/E
33
Price to Book Value
5.86
EV to EBIT
32.70
EV to EBITDA
26.24
EV to Capital Employed
5.18
EV to Sales
2.34
PEG Ratio
0.72
Dividend Yield
NA
ROCE (Latest)
15.85%
ROE (Latest)
16.98%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

15What is working for the Company
ROCE(HY)

Highest at 20.65%

PAT(Q)

At Rs 2.57 cr has Grown at 65.8%

DEBTORS TURNOVER RATIO(HY)

Highest at 2.99 times

NET SALES(Q)

Highest at Rs 52.64 cr

-3What is not working for the Company
INVENTORY TURNOVER RATIO(HY)

Lowest at 4.15 times

NON-OPERATING INCOME(Q)

is 49.57 % of Profit Before Tax (PBT

Loading Valuation Snapshot...

Here's what is working for Medico Remedies

Profit After Tax (PAT) - Quarterly
At Rs 2.57 cr has Grown at 65.8%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly
Highest at Rs 52.64 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Net Sales - Quarterly
At Rs 52.64 cr has Grown at 33.77%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Debtors Turnover Ratio- Half Yearly
Highest at 2.99 times
in the last five half yearly periods
MOJO Watch
Company has been able to settle its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Medico Remedies

Inventory Turnover Ratio- Half Yearly
Lowest at 4.15 times and Fallen
each half year in the last five half yearly periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Non Operating Income - Quarterly
is 49.57 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model

Non Operating Income to PBT